To investigate the role of NKILA in gliomas, we used qRT-PCR to measure the expression levels of NKILA in 15 clinical GBM tissue samples, 10 clinical LGG tissue samples, and 10 normal brain tissue samples. The gene discussed is NKILA; the disease is central nervous system cancer.